Precision Medicine for Alzheimer's Disease Prevention

Healthcare
C L BerkowitzR S Isaacson

Abstract

Precision medicine is an approach to medical treatment and prevention that takes into account individual variability in genes, environment, and lifestyle and allows for personalization that is based on factors that may affect the response to treatment. Several genetic and epigenetic risk factors have been shown to increase susceptibility to late-onset Alzheimer's disease (AD). As such, it may be beneficial to integrate genetic risk factors into the AD prevention approach, which in the past has primarily been focused on universal risk-reduction strategies for the general population rather than individualized interventions in a targeted fashion. This review discusses examples of a "one-size-fits-all" versus clinical precision medicine AD prevention strategy, in which the precision medicine approach considers two genes that can be commercially sequenced for polymorphisms associated with AD, apolipoprotein E (APOE), and methylenetetrahydrofolate reductase (MTHFR). Comparing these two distinct approaches provides support for a clinical precision medicine prevention strategy, which may ultimately lead to more favorable patient outcomes as the interventions are targeted to address individualized risks.

References

Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Jul 17, 2001·Dementia and Geriatric Cognitive Disorders·A McCaddonC Wilkinson
Feb 15, 2002·The New England Journal of Medicine·Sudha SeshadriPhilip A Wolf
Apr 30, 2003·The American Journal of Clinical Nutrition·Lindsey F MassonAlison Avenell
Jul 22, 2004·Genetics in Medicine : Official Journal of the American College of Medical Genetics·L Adrienne CupplesRobert C Green
Aug 25, 2005·Alzheimer Disease and Associated Disorders·John C Morris
Jan 16, 2007·Medicine and Science in Sports and Exercise·Jennifer L EtnierElisabeth C McLemore
Nov 10, 2007·The American Journal of Clinical Nutrition·Robert ClarkeJohn Grimley Evans
Sep 5, 2008·JAMA : the Journal of the American Medical Association·Nicola T LautenschlagerOsvaldo P Almeida
Mar 31, 2009·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Sophie Gillette-GuyonnetUNKNOWN MAPT Study Group
Apr 14, 2009·Progress in Lipid Research·S C CunnaneP Barberger-Gateau
Jul 17, 2009·The New England Journal of Medicine·Robert C GreenUNKNOWN REVEAL Study Group
Aug 4, 2009·Dementia and Geriatric Cognitive Disorders·Alina SolomonRachel A Whitmer
Oct 9, 2009·Alzheimer Disease and Associated Disorders·Edo RichardWillem A Van Gool
Mar 20, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael W LutzAllen D Roses
Mar 5, 2011·Lancet·Clive BallardEmma Jones
Dec 22, 2011·Journal of Aging and Physical Activity·Yu-Kai ChangChi-Chang Huang
Apr 14, 2012·The Journal of Nutrition, Health & Aging·I CarriéB Vellas
Jan 22, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Miia KivipeltoHilkka Soininen
May 11, 2013·Clinical Neurology and Neurosurgery·Leila MansouriRidha Mrissa
May 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Gwenaëlle DouaudA David Smith
Mar 20, 2014·Genes & Nutrition·Elena H Martínez-LapiscinaMiguel A Martinez-Gonzalez
Jan 31, 2015·Expert Review of Molecular Diagnostics·Christiane Reitz
Mar 19, 2015·PloS One·Karin Yurko-MauroMary E Van Elswyk
Jul 15, 2015·Current Nutrition Reports·Lisa Mosconi, Pauline F McHugh
Aug 26, 2015·JAMA : the Journal of the American Medical Association·Kaycee M SinkUNKNOWN LIFE Study Investigators
Aug 28, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Caroline Van CauwenbergheKristel Sleegers
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Gustavo C Román
Feb 3, 2016·JAMA : the Journal of the American Medical Association·Martha Clare MorrisOndine van de Rest
Feb 19, 2016·Journal of Alzheimer's Disease : JAD·Nadine KülzowAgnes Flöel
Apr 3, 2016·Neurobiology of Aging·Perry G RidgeUNKNOWN Alzheimer's Disease Genetics Consortium (ADGC)

❮ Previous
Next ❯

Citations

Jun 28, 2019·Frontiers in Physiology·Patrick MüllersNotger G Müller
Jun 12, 2019·Molecular Neurobiology·Vivian R JaberWalter J Lukiw
Jan 30, 2021·Neural Regeneration Research·Benjamin SinyorChristopher Ochner
Sep 12, 2021·Ageing Research Reviews·Chinedu Udeh-MomohUNKNOWN Female Brain Health and Endocrine Research (FEMBER) consortium
Dec 8, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Yizhe GaoUNKNOWN CHAP, UKBB, ADNI, ROSMAP, LLFS, NIA-LOAD and ADGC consortia

❮ Previous
Next ❯

Software Mentioned

Alzgene

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Related Papers

The Journal of Prevention of Alzheimer's Disease
C L BerkowitzR S Isaacson
Arquivos de neuro-psiquiatria
Liana Lisboa Fernandez, Rosane Machado Scheibe
Journal of Medical Genetics
A G YipMedical Research Council Cognitive Function Ageing Study (MRC CFAS)
© 2022 Meta ULC. All rights reserved